Navigation Links
Epigenetic signatures direct the repair potential of reprogrammed cells
Date:3/14/2012

ndicate its expression, we can determine the reprogrammed cells' potential for maintaining normal cellular characteristics throughout development," said first author Kyle Hewitt, PhD, a graduate of the cell, molecular & developmental biology program at the Sackler School of Graduate Biomedical Sciences, and postdoctoral associate in the Garlick laboratory at Tufts University School of Dental Medicine (TUSDM).

"The ability to generate patient-specific cells from the reprogrammed skin cells may allow for improved, individualized, cell-based therapies for wound healing. Potentially, these reprogrammed cells could be used as a tool for drug development, modeling of disease, and transplantation medicine without the ethical issues associated with embryonic stem cells," said senior author Jonathan Garlick, DDS, PhD, a professor in the department of oral and maxillofacial pathology and director of the division of tissue engineering and cancer biology at TUSDM.

Jonathan Garlick is also a member of the cell, molecular & developmental biology program faculty at the Sackler School and the director of the Center for Integrated Tissue Engineering (CITE) at TUSDM.


'/>"/>

Contact: Jessica McGovern
jessica.mcgovern@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

Page: 1 2

Related biology news :

1. CSHL scientists discover a new way in which epigenetic information is inherited
2. CSHL researchers map changing epigenetic modifications that enable transposons to run amok
3. Growth of new brain cells requires epigenetic switch
4. Ali Shilatifard and colleagues aim to clarify the definition of epigenetics
5. New nucleotide could revolutionize epigenetics
6. New piece found in the puzzle of epigenetics
7. Scientists take early steps toward mapping epigenetic variability
8. Epigenetics could help researchers determine any risks associated with low-dose radiation
9. Genomes of identical twins reveal epigenetic changes that may play role in lupus
10. UBC geneticist reveals molecular view of key epigenetic regulator
11. Epigenetic concepts offer new approach to degenerative disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... release is available in German . ... sensory modalities for orientation, some of which might be ... take the polarization pattern produced by sunlight in the ... the Max Planck Institute for Ornithology in Seewiesen, Germany, ... Israel that a night active mammal, the greater mouse-eared ...
(Date:7/23/2014)... for Alzheimer,s disease, the devastating neurological disease affecting ... now reporting new progress on a set of ... promise as a potential oral therapy for Alzheimer,s. ... Medicinal Chemistry . , Carlo Ballatore, Kurt R. ... brain, the protein known as tau binds to ...
(Date:7/23/2014)... culinary herbs oregano and rosemary are packed with healthful ... in much the same way as prescription anti-diabetic medication, ... Journal of Agricultural and Food Chemistry , they ... difference, and they also identified which compounds contribute the ... Mejia and colleagues point out that in 2012, type-2 ...
Breaking Biology News(10 mins):Bats use the evening sky's polarization pattern for orientation 2
... to approve a human trial of gene therapy for cystic fibrosis ... on monkeys show the hybrid virus delivers genes to the lungs ... while the idea of combining two killer viruses sounds horrifying, the ... managed to develop an effective form of gene therapy to treat ...
... a recently published article in Environmental MicrobiologyAn unusual relationship ... worms is the only known partnership (or symbiosis) which ... nutrition. , In the September issue of Environmental Microbiology, ... partnership between bacteria and the Osedax (bone-devouring) group of ...
... the University of Illinois at Chicago shows promise in ... respiratory syndrome, or SARS. , Currently, there are no ... almost 800 people in an epidemic in 2002-2003. , ... received an $8 million grant from the National Institute ...
Cached Biology News:Can two killers make a cure? 2UIC developing drug for SARS 2UIC developing drug for SARS 3
(Date:7/23/2014)... Physicists Sergei Filippov (MIPT and Russian Quantum Center ... Brno, Czech Republic, and the Institute of Physics ... preserve quantum entanglement of particles passing through an ... long distances. Details are provided in an article ... (see preprint). , Quantum entangled particles are ...
(Date:7/23/2014)... Shimadzu Scientific Instruments has launched the ... developed jointly with Ajinomoto Co. Inc. Offering simultaneous ... amino acids in nine minutes, drastically enhancing laboratory ... utilizing a fast application-specific column and an LCMS-2020 ... even under conditions with difficult samples that contain ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
(Date:7/23/2014)... regulated information -- UCB today announced an ... with positive topline results from the latest Phase ... designed to evaluate the efficacy and safety of ... titration) compared to placebo, as adjunctive treatment in ... fully controlled despite treatment with one or two ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... , CINCINNATI, Sept. 18 LCA-Vision Inc. (Nasdaq: ... correction services under the Lasik Plus (R) brand, announces that ... a member of the company,s board of directors effective September ... ophthalmology industry. Management of daily operations will be the ...
... N.J., Sept. 17 Regado Biosciences, a privately held company ... announced today that the European Patent Office (EPO) has notified ... claims directed to oligonucleotide modulators of blood coagulation factor aptamers ... Company,s portfolio extends the scope and breadth of Regado,s intellectual ...
... , , , , ... The US Food and Drug Administration (FDA) has approved Valturna(R) ... two key points within the renin system, also known as the ... This is the first approval for Valturna, which is indicated for ...
Cached Biology Technology:LCA-Vision Announces CEO Resignation 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 3Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 2Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 3Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 4Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 5Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 6Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 7
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
GOAT ANTI FRK...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: